Bionomics Share Holder Equity 2022-2024 | NEUP
Bionomics share holder equity from 2022 to 2024. Share holder equity can be defined as the sum of preferred and common equity items
Bionomics Annual Share Holder Equity
(Millions of US $) |
| 2024 |
$17 |
| 2023 |
$22 |
| 2022 |
$41 |
| 2021 |
$36 |
Bionomics Quarterly Share Holder Equity
(Millions of US $) |
| 2024-09-30 |
$17 |
| 2024-06-30 |
$17 |
| 2023-09-30 |
$0 |
| 2023-06-30 |
$22 |
| 2022-12-31 |
$31 |
| 2022-06-30 |
$41 |
| 2021-06-30 |
$36 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.010B |
$0.000B |
|
Bionomics Limited is a clinical-stage biopharmaceutical developing novel, allosteric ion channel modulators designed to transform the lives of patients suffering from serious central nervous system disorders. Bionomics Limited is based in ADELAIDE, Australia.
|
